What Researchers Did
Researchers investigated the impact of hyperbaric oxygenation on circulatory function in 61 patients with rheumatic mitral valve disease and systemic circulatory insufficiency.
What They Found
In 61 patients, a course of 10-14 daily hyperbaric oxygenation exposures at 0.7-1.0 ATA led to a reduction in heart volume and arterial and central venous pressure. They also observed an acceleration of blood flow within the heart and body, an increase in stroke index, and improved blood flow in extremity muscles, indicating enhanced myocardial contractility.
What This Means for Canadian Patients
While this 1977 study suggests potential benefits of hyperbaric oxygenation for circulatory function in rheumatic mitral valve disease, current medical practice for this condition has significantly advanced. Canadian patients with rheumatic heart disease would typically receive modern pharmacological and surgical interventions, making this specific treatment approach largely historical.
Canadian Relevance
This study has no direct Canadian connection or relevance, as it was conducted in 1977 and published in a Russian journal.
Study Limitations
A limitation of this study is the absence of a control group, which makes it difficult to definitively attribute the observed improvements solely to hyperbaric oxygenation.